Search Results 341-350 of 29812 for Pulmonary

  1. SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT - Mayo Clinic

    The exploratory objective is to explore the effects of macitentan on PAH symptoms and their impact (as measured by the PAH-SYMPACT) in patients with pulmonary ...

  2. Expiratory central airway collapse is challenging to identify and underdiagnosed - Mayo Clinic

    Chronic obstructive pulmonary disease; Asthma; Obesity; Gastroesophageal reflux disease. Diagnosis of ECAC. "The clinical manifestations of ECAC are so common ...

  3. Robert P. Frantz, M.D. - Mayo Clinic Faculty Profiles

    Pathophysiology of pulmonary vascular disease. Dr. Frantz is studying the factors responsible for pulmonary hypertension across the varying underlying ...

  4. Pediatric torso injuries present unique challenges - Mayo Clinic

    Pulmonary contusions may not always show up on the initial X-ray, but they should be suspected in any child with rib fractures because extreme force is needed ...

  5. Early Identification of Pulmonary Coccidioidomycosis - Mayo Clinic

    The purpose of this study is to identify, recruit, and enroll patients with community-acquired pneumonia (CAP) to collect their blood, sputum, urine, and a ...

  6. Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement - Mayo Clinic

    About this study. PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to ...

  7. Lung Transplant - Doctors - Mayo Clinic

    Cystic fibrosis, Interstitial lung disease, Pulmonary fibrosis, Hepatopulmonary syndrome, Pulmonary valve disease, Advanced lung disease. Show more areas of ...

  8. Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis - Mayo Clinic

    ... Pulmonary Fibrosis (IPF). Secondary Objectives: To evaluate the efficacy of 2 dose levels of SAR156597 compared to placebo on IPF disease progression. To ...

  9. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of namilumab in subjects with chronic pulmonary sarcoidosis (CPS). Sarcoidosis is a multi-organ ...

  10. An Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse (TGD) Patients - Mayo Clinic

    Also, to determine the time of “gender adjustment” of PFT's (pulmonary function test) normative values (PFTs results correlate most closely with patient's ...